Scinai Immunotherapeutics (FRA:2F5) Cyclically Adjusted Book per Share: €30.35 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:2F5 Scinai Immunotherapeutics Ltd FRA:2F5
20 GF Score
Price €0.21
! 4 Warning Signs
View Full Analysis

What is Scinai Immunotherapeutics Cyclically Adjusted Book per Share?

Scinai Immunotherapeutics FRA:2F5 -0.94% 20 Cyclically Adjusted Book per Share is €30.35 as of Mar. 2026. GuruFocus rates FRA:2F5 with a GF Score™ of 20/100. The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Scinai Immunotherapeutics's adjusted book value per share for the three months ended in Mar. 2026 was €1.501. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €30.35 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Scinai Immunotherapeutics's average Cyclically Adjusted Book Growth Rate was -43.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-07-26), Scinai Immunotherapeutics's current stock price is €0.21. Scinai Immunotherapeutics's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was €30.35. Scinai Immunotherapeutics's Cyclically Adjusted PB Ratio of today is 0.01.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Scinai Immunotherapeutics was 0.06. The lowest was 0.01. And the median was 0.03.


Scinai Immunotherapeutics  (FRA:2F5) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Scinai Immunotherapeutics's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=0.21/30.35
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Scinai Immunotherapeutics was 0.06. The lowest was 0.01. And the median was 0.03.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Scinai Immunotherapeutics Cyclically Adjusted Book per Share Related Terms


Scinai Immunotherapeutics Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Scinai Immunotherapeutics's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Scinai Immunotherapeutics Cyclically Adjusted Book per Share Chart

Scinai Immunotherapeutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 80.27 60.85 34.00

Scinai Immunotherapeutics Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 60.85 0.00 119.11 34.00 30.35

FRA:2F5 vs ABPO, ISCO, ZVSA: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Scinai Immunotherapeutics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Scinai Immunotherapeutics Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Scinai Immunotherapeutics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Scinai Immunotherapeutics's Cyclically Adjusted PB Ratio falls into.


FRA:2F5
20GF Score
Scinai Immunotherapeutics Ltd FRA:2F5
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Scinai Immunotherapeutics Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Scinai Immunotherapeutics's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=1.501/330.2130*330.2130
=1.501

Current CPI (Mar. 2026) = 330.2130.

Scinai Immunotherapeutics Quarterly Data

Book Value per Share CPI Adj_Book
201603 224.794 238.132 311.717
201606 203.176 241.018 278.367
201609 194.147 241.428 265.544
201612 185.676 241.432 253.954
201703 223.088 243.801 302.159
201706 119.022 244.955 160.448
201709 251.046 246.819 335.868
201712 210.400 246.524 281.826
201803 149.692 249.554 198.074
201806 60.154 251.989 78.827
201809 52.969 252.439 69.288
201812 -112.077 251.233 -147.311
201903 -114.800 254.202 -149.127
201906 -276.262 256.143 -356.150
201909 -52.733 256.759 -67.819
201912 -167.396 256.974 -215.105
202003 -150.854 258.115 -192.991
202006 -138.704 257.797 -177.666
202009 -3.939 260.280 -4.997
202012 -32.443 260.474 -41.129
202103 36.594 264.877 45.620
202106 20.301 271.696 24.673
202109 7.727 274.310 9.302
202112 4.697 278.802 5.563
202203 24.812 287.504 28.498
202206 6.513 296.311 7.258
202209 14.182 296.808 15.778
202212 -6.725 296.797 -7.482
202303 -13.698 301.836 -14.986
202306 -18.083 305.109 -19.571
202309 -5.798 307.789 -6.220
202312 -9.030 306.746 -9.721
202403 -8.717 312.332 -9.216
202406 -8.085 314.175 -8.498
202409 4.623 315.301 4.842
202412 4.870 315.605 5.095
202503 0.000 319.799 0.000
202506 1.277 322.561 1.307
202512 0.610 324.054 0.622
202603 1.501 330.213 1.501

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €30.35 mean?
Scinai Immunotherapeutics (FRA:2F5) has a Cyclically Adjusted Book per Share of €30.35 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Scinai Immunotherapeutics and its competitors.
Is Scinai Immunotherapeutics' Cyclically Adjusted Book per Share too high?
Scinai Immunotherapeutics' current Cyclically Adjusted Book per Share is €30.35. Overall, Scinai Immunotherapeutics has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Scinai Immunotherapeutics' Cyclically Adjusted Book per Share compare to ABPO and ISCO?
Scinai Immunotherapeutics' Cyclically Adjusted Book per Share of €30.35 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Scinai Immunotherapeutics and its competitors. Scinai Immunotherapeutics's current Cyclically Adjusted Book per Share is €30.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scinai Immunotherapeutics stock overvalued right now?
Scinai Immunotherapeutics (FRA:2F5) has a current Cyclically Adjusted Book per Share of €30.35. The current Cyclically Adjusted Book per Share is €30.35. Scinai Immunotherapeutics' overall GF Score™ is 20/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Scinai Immunotherapeutics (FRA:2F5), the current Cyclically Adjusted Book per Share is €30.35 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Scinai Immunotherapeutics Business Description

Other Exchanges SCNI:USA
Address Hadassah Ein Kerem Campus, 2nd Floor, Jerusalem BioPark, Jerusalem, ISR
Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units: (i) Scinai R&D, focused on the development of therapeutics in inflammation and immunology, and (ii) the contract development and manufacturing organization (CDMO) business. The CDMO business provides integrated development and manufacturing services to small and emerging biotech companies, supporting clients from early-stage development through clinical-stage production.
20GF Score

Get the complete analysis for FRA:2F5

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.21
Price